‘TumorPrint’ project for the printing of human cancer models receives EU funding
CELLINK (Gothenburg, Sweden) have been a €2.5 million grant from the European Commission to develop and commercialize their project, ‘TumorPrint’, for the benefit of research into cancer tumors and their cellular reactions to different pharmaceutical compounds.
Please sign in or register for FREE
Sign in to 3DMedNet
Register to 3DMedNet
3DMedNet is a free content and networking hub aiming to encourage knowledge-sharing, interaction and discussion within the diverse 3D printing in medicine and healthcare community.